Corcept Therapeutics Incorporated Profile Avatar - Palmy Investing

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral m…

Biotechnology
US, Menlo Park [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Corcept Therapeutics Incorporated mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CORT's Analysis
CIK: 1088856 CUSIP: 218352102 ISIN: US2183521028 LEI: - UEI: -
Secondary Listings
CORT has no secondary listings inside our databases.